WATCH NOW
A father smiles at his young daughter as he holds her up.
 

Now Available: "Expert Insights on Diagnostics and Antimicrobial Resistance"

ESCMID Global 2025 Integrated Symposium

We’re thrilled to announce that the Integrated Symposium is now live and available to watch on demand!

 

The Integrated Symposium emphasized the critical role of diagnostics in combating antimicrobial resistance (AMR). Experts highlighted the importance of molecular diagnostics to enhance patient pathways and improve healthcare delivery. 

 

Watch now and be part of the solution.

 

 

CEPHEID INTEGRATED SYMPOSIUM

Expert Insights on Diagnostics and Antimicrobial Resistance

Chair: Dr. Devasena Gnanashanmugam, Vice President, Medical Affairs, Cepheid, USA 
ESCMID-appointed Chair: Pr. Laurent Dortet, Hôpital de Bicêtre, France

 
 

Protecting Patient Pathways and Healthcare Delivery through the Intelligent Use of Diagnostics

Pr. Alison Holmes

Professor of Infectious Diseases, Imperial College, The David Price Evans Chair of Global Health and Infectious Diseases, University of Liverpool, and Director of the Fleming Initiative, Imperial College London

 

Rapid Respiratory Testing: Experience of POC and laboratory molecular testing in a large teaching hospital Trust

Dr. Nick Machin

Consultant Virologist, Manchester University Foundation Trust, U.K.

 

The Kentucky Viral Hepatitis Treatment (KeY Treat) Trial: A Model of Care in a Rural Appalachian County, U.S.

Dr. Jennifer R. Havens 

Infectious disease epidemiologist and Professor in the Department of Behavioral Science, University of Kentucky College of Medicine (UKCOM), USA

 

Antimicrobial Resistance, an Update from the Middle East

Dr. Mohammed Al Zunitan

Deputy Executive Director, Infection Prevention and Control Program, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, KSA

 

Impact of Carbapenemase-PCR in Outbreak Management — Cost vs. Benefit

PD Dr. Thomas Bollinger

Institute Director, Specialist in Microbiology, Virology and Infection Epidemiology Specialist Immunologist, Deutschen Gesellschaft für Immunologie (DGFI), Germany

 

 

CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.

Access now the ESCMID Global 2025 Cepheid Symposium Recording:

 

I would like to be part of the Cepheid Community and I understand and consent to receive information about products and services, invitations to virtual and in-person events such as workshops and webinars and educational content from Cepheid and similar information from Cepheid’s affiliates and representatives.

*required fields
Cepheid respects your privacy, and values the relationship with our customers, partners, and associates. Your personal data may be processed by Cepheid, its affiliates, representatives and other Danaher companies for business and marketing purposes. You can review Cepheid Privacy Policy online for additional information on your rights and how we use and share personal data we collect on our websites and other channels. Your consent to receiving Cepheid news can be withdrawn at any time. Building a relationship of trust is important to us and we will happily help with any questions on your personal data processing addressed to Privacy.officer@cepheid.com

About Cepheid

Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most from central laboratories and hospitals to near patient settings.

For more information, visit www.cepheid.com

©2025 Cepheid. All Rights Reserved.